| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Aeglea BioTherapeutics, Inc. | Director | Director Stock Option (right to buy) | 43K | Jun 7, 2022 | Direct | ||
| CRISPR Therapeutics AG | Director | Stock Option (Right to Buy) | 13K | May 30, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| CRSP | CRISPR Therapeutics AG | May 30, 2024 | 1 | $0 | 4 | May 31, 2024 | Director |
| CRSP | CRISPR Therapeutics AG | May 30, 2024 | 0 | $0 | 3 | May 30, 2024 | Director |
| AGLE | Aeglea BioTherapeutics, Inc. | Jun 7, 2022 | 1 | $0 | 4 | Jun 9, 2022 | Director |
| AGLE | Aeglea BioTherapeutics, Inc. | Jun 8, 2021 | 1 | $0 | 4 | Jun 9, 2021 | Director |